Seres Therapeutics Income Statement (2015-2025) | MCRB

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 2.71M3.00M13.02M3.04M3.02M3.01M23.02M3.06M3.77M4.27M8.68M10.63M7.32M12.53M7.03M7.62M8.19M6.04M1.42M17.56M5.72M5.26M126.72M7.22M1.49M1.22M3.44M0.97M0.52M126.47M0.31M0.06M-0.62M0.35M
Operating items
Research & Development 5.56M9.85M13.90M15.42M22.17M24.14M20.26M20.14M23.06M22.21M24.04M23.46M24.05M23.68M24.77M22.89M17.91M18.32M21.03M21.74M20.10M23.86M24.87M29.30M35.95M39.88M36.75M39.65M43.94M43.12M-17.05M43.97M46.79M25.15M23.04M19.49M15.81M16.46M12.84M11.82M12.94M12.62M
Selling, General & Administrative 2.61M4.71M5.89M7.21M8.97M7.97M8.45M8.76M8.37M8.12M8.79M8.78M8.70M7.59M7.53M7.50M5.57M5.90M5.78M6.14M6.49M7.55M10.60M11.74M17.45M19.56M20.51M18.57M20.34M18.38M12.97M22.47M28.05M19.43M13.98M14.94M13.06M12.71M12.46M11.89M10.25M9.48M
Restructuring Costs 1.49M
Other Operating Expenses 0.02M1.13M0.60M0.98M-0.27M1.05M-0.35M3.61M2.11M3.53M2.18M0.18M0.74M
Operating Expenses 8.17M14.56M19.79M22.63M31.14M32.11M28.73M28.91M31.43M30.33M32.83M32.24M32.75M31.27M32.30M31.87M23.48M24.21M26.81M27.88M26.59M31.41M35.46M41.04M53.41M58.32M56.65M57.24M64.54M62.55M-4.42M70.05M76.95M44.59M37.02M34.44M28.87M29.17M28.84M27.24M24.88M22.83M
Operating Income -8.17M-14.56M-19.79M-19.92M-28.14M-19.09M-25.69M-25.89M-28.42M-7.31M-29.77M-28.27M-28.14M-22.21M-21.67M-24.55M-10.95M-17.18M-19.19M-19.69M-20.55M-30.00M-17.90M-35.33M-48.14M68.41M-49.43M-55.75M-63.33M-59.11M-1.73M-70.57M49.52M-44.59M-37.02M-34.44M-28.87M-29.17M-28.84M-27.24M-24.88M-22.48M
EBIT -8.17M-14.56M-19.79M-19.92M-28.14M-19.09M-25.69M-25.89M-28.42M-7.31M-29.77M-28.27M-28.14M-22.21M-21.67M-24.55M-10.95M-17.18M-19.19M-19.69M-20.55M-30.00M-17.90M-35.33M-48.14M68.41M-49.43M-55.75M-63.33M-59.11M-1.73M-70.57M49.52M-44.59M-37.02M-34.44M-28.87M-29.17M-28.84M-27.24M-24.88M-22.48M
Non-operating items
Interest & Investment Income 0.27M0.49M0.72M-0.22M0.78M0.61M0.50M-0.30M0.35M0.35M0.26M0.21M0.22M0.19M0.34M0.29M0.16M0.07M0.10M0.61M0.97M0.83M0.59M0.48M0.38M0.40M0.86M1.41M1.03M1.73M2.57M1.97M1.65M1.23M0.65M0.44M0.62M0.55M0.62M
Other Non Operating Income 0.21M-0.06M-0.27M-0.31M-0.36M-0.22M-0.12M1.12M0.44M0.63M0.37M0.48M0.34M-0.21M-0.41M-0.28M-0.04M-0.32M-0.34M-0.30M-0.03M-0.02M0.31M-1.51M1.00M0.34M0.51M1.45M-22.52M7.08M7.12M4.29M2.84M
Non Operating Income 0.20M-0.06M0.15M0.21M-0.27M0.41M0.40M0.42M0.40M0.38M0.82M0.35M0.35M0.26M0.38M0.22M0.19M0.77M0.41M0.37M0.48M0.34M-2.19M-0.41M-0.28M-0.19M-0.36M-0.87M-1.41M-0.90M-0.49M-0.61M-2.97M3.57M2.31M1.53M2.67M-22.52M7.08M59.92M5.03M30.68M
Net income details
EBT -8.17M-14.56M-19.79M-19.65M-27.64M-18.38M-25.91M-25.11M-27.80M-6.81M-30.08M-27.92M-27.79M-21.95M-21.46M-24.33M-10.76M-16.85M-18.90M-20.25M-21.19M-30.62M-18.04M-35.06M-48.05M68.25M-49.69M-56.28M-64.43M-59.97M-2.20M-71.48M48.06M-42.01M-35.05M-33.41M-27.64M-28.52M-28.40M-26.62M-24.34M-21.86M
Profit After Tax -7.97M-14.62M-19.63M-19.70M-27.91M-18.69M-25.27M-25.47M-28.02M-6.93M-28.95M-27.92M-27.79M-21.95M-21.29M-24.33M-10.76M-16.41M-18.78M-19.88M-20.71M-30.28M-18.25M-35.47M-48.33M68.22M-50.00M-56.62M-64.73M-60.00M-68.80M-71.17M46.55M-47.85M-34.72M-40.13M-32.87M88.78M-15.64M32.68M-19.86M8.20M
Income from Continuing Operations -8.17M-14.56M-19.79M-19.65M-27.64M-18.38M-25.91M-25.11M-27.80M-6.81M-30.08M-27.92M-27.79M-21.95M-21.46M-24.33M-10.76M-16.85M-18.90M-20.25M-21.19M-30.62M-18.04M-35.06M-48.05M68.25M-49.69M-56.28M-64.43M-59.97M-2.20M-71.48M48.06M-42.01M-35.05M-33.41M-27.64M-28.52M-28.40M-26.62M-24.34M-21.86M
Consolidated Net Income -8.17M-14.56M-19.79M-19.65M-27.64M-18.38M-25.91M-25.11M-27.80M-6.81M-30.08M-27.92M-27.79M-21.95M-21.46M-24.33M-10.76M-16.85M-18.90M-20.25M-21.19M-30.62M-18.04M-35.06M-48.05M68.25M-49.69M-56.28M-64.43M-59.97M-2.20M-71.48M48.06M-6.84M-6.53M-7.23M-6.67M139.81M-28.40M-26.62M-24.34M-21.86M
Income towards Parent Company -8.17M-14.56M-19.79M-19.65M-27.64M-18.38M-25.91M-25.11M-27.80M-6.81M-30.08M-27.92M-27.79M-21.95M-21.46M-24.33M-10.76M-16.85M-18.90M-20.25M-21.19M-30.62M-18.04M-35.06M-48.05M68.25M-49.69M-56.28M-64.43M-59.97M-2.20M-71.48M48.06M-6.84M-6.53M-7.23M-6.67M139.81M-28.40M-26.62M-24.34M-21.86M
Net Income towards Common Stockholders -8.17M-14.56M-19.79M-19.65M-27.64M-18.38M-25.91M-25.11M-27.80M-6.81M-30.08M-27.92M-27.79M-21.95M-21.46M-24.33M-10.76M-16.85M-18.90M-20.25M-21.19M-30.62M-18.04M-35.06M-48.05M68.22M-50.00M-56.62M-64.73M-60.00M-68.80M-71.17M46.55M-6.84M-6.53M-40.13M-32.87M139.81M-28.40M32.68M-24.34M-21.86M
Additional items
EPS (Basic) -1.19-0.38-0.50-0.50-0.70-0.46-0.63-0.63-0.69-0.17-0.72-0.69-0.68-0.54-0.52-0.59-0.24-0.23-0.27-0.28-0.28-0.36-0.19-0.39-0.530.74-0.55-0.61-0.70-0.49-0.54-0.570.36-0.37-0.27-5.49-4.3411.6313.873.76-2.270.94
EPS (Weighted Average and Diluted) -0.36-0.19-0.380.72-0.55-0.61-0.70-0.49-0.54-0.570.36-0.37-0.27-5.49-4.3411.6313.873.75-2.270.94
Shares Outstanding (Weighted Average) 1.83M1.95M1.95M1.96M1.98M2.01M2.02M2.02M2.02M2.03M2.03M2.03M2.03M2.04M2.04M2.05M2.05M3.50M3.50M3.55M3.63M3.81M4.56M4.58M4.58M4.59M4.59M4.60M4.61M6.20M6.23M6.30M6.40M6.41M6.46M7.55M7.57M7.59M8.54M8.72M8.73M8.75M
Shares Outstanding (Diluted Average) 79.79M91.66M94.95M91.70M92.16M92.26M122.53M108.08M125.86M129.84M128.29M128.00M7.31M152.65M155.40M8.71M
EBITDA -7.94M-14.65M-19.59M-19.63M-27.94M-18.84M-25.36M-25.48M-28.04M-6.86M-29.00M-27.88M-27.71M-21.93M-21.28M-24.33M-10.76M-16.40M-18.79M-19.89M-20.70M-30.28M-18.30M-35.43M-48.30M68.22M-50.07M-56.78M-64.78M-59.86M-68.69M-71.16M46.55M-47.85M-41.25M-40.13M-32.87M88.78M-15.64M-27.24M-24.88M-22.48M
Interest Expenses 0.72M0.72M0.73M0.76M0.70M0.73M0.74M0.74M0.91M1.50M1.73M1.88M1.95M3.19M0.62M